Investigation into the mechanism of action of essential oil of Pistacia integerrima for its antiasthmatic activity

Journal of Ethnopharmacology

Volumn 153, Issue 3, 2014, Pages 541-551

  Shirole, R L ^a   Shirole, N L ^c   Kshatriya, A A ^a   Kulkarni, R ^b   Saraf, M N ^a  

^a BOMBAY COLLEGE OF PHARMACY   (India)

^b BYL NAIR CHARITABLE HOSPITAL   (India)

^c A R A College of Pharmacy Dhule   (India)

Author keywords

Asthma; Essential oil; Lipopolysaccharide; Pistacia integerrima J.L. Stewart ex Brandis; Spirometry

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; 1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; ACETYLCHOLINE; ALBUMIN; CALCIUM; CALCIUM CHANNEL L TYPE; ERYTHROPOIETIN; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; ESSENTIAL OIL; ESSENTIAL OIL OF PISTACIA INTEGERRIMA; KETOTIFEN FUMARATE; LIPOXYGENASE; MYELOPEROXIDASE; NITRATE; NITRITE; OVALBUMIN; PLANT MEDICINAL PRODUCT; PROTEIN; ROFLUMILAST; UNCLASSIFIED DRUG; 4 METHOXY N METHYLPHENETHYLAMINE; ALLERGEN; ANGIOGENESIS INHIBITOR; ANTIASTHMATIC AGENT; ANTIOXIDANT; ARACHIDONATE 5 LIPOXYGENASE; LIPOPOLYSACCHARIDE; LIPOXYGENASE INHIBITOR; PEROXIDASE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ASTHMA; BILE; CELL COUNT; CONTROLLED STUDY; CULTURE MEDIUM; DRUG INHIBITION; ENZYME ACTIVITY; FEMALE; GUINEA PIG; IC 50; ILEUM; IN VITRO STUDY; IN VIVO STUDY; LUNG HOMOGENATE; LUNG LAVAGE; MALE; MAST CELL DEGRANULATION; MEDICINAL PLANT; MOUSE; NEUTROPHIL COUNT; NONHUMAN; OVALBUMIN-INDUCED BRONCHOCONSTRICTION; PISTACIA; PISTACIA INTEGERRIMA; RAT; RESPIRATORY AIRFLOW; RESPIRATORY TRACT ALLERGY; SCAVENGING SYSTEM; SOYBEAN; SPIROMETRY; ANIMAL; BRONCHOCONSTRICTION; CHEMICALLY INDUCED; CYTOLOGY; DRUG EFFECTS; HISTAMINE RELEASE; LUNG; MAST CELL; METABOLISM; MUSCLE CONTRACTION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PNEUMONIA; SPRAGUE DAWLEY RAT; ZYGOTE;

CAVIA; PISTACIA INTEGERRIMA; RATTUS;

ALLERGENS; ANGIOGENESIS INHIBITORS; ANIMALS; ANTI-ASTHMATIC AGENTS; ANTIOXIDANTS; ARACHIDONATE 5-LIPOXYGENASE; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOCONSTRICTION; CELL COUNT; FEMALE; GUINEA PIGS; HISTAMINE RELEASE; ILEUM; LIPOPOLYSACCHARIDES; LIPOXYGENASE INHIBITORS; LUNG; MALE; MAST CELLS; MICE; MUSCLE CONTRACTION; NEOVASCULARIZATION, PHYSIOLOGIC; OILS, VOLATILE; OVALBUMIN; P-METHOXY-N-METHYLPHENETHYLAMINE; PEROXIDASE; PISTACIA; PNEUMONIA; RATS, SPRAGUE-DAWLEY; ZYGOTE;

EID: 84900321824     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2014.02.009     Document Type: Article

References (71)

1. D. Adamko, S.O. Odemuyiwa, and R. Moqbel The eosinophil as a therapeutic target in asthma: beginning of the end, or end of the beginning? Curr. Opin. Pharmacol. 3 2003 227 232
2. S. Adusumalli, P.M. Ranjit, and M.S. Harish Antiasthmatic activity of acqueous extract of Pistacia integerrima galls Int. J. Pharm. Pharm. Sci. 5 2013 116 121
3. N.S. Ahmad, M. Farman, M.H. Najmi, K.B. Mian, and A. Hasan Pharmacological basis for use of Pistacia integerrima leaves in hyperuricemia and gout J. Ethnopharmacol. 117 2008 478 482
4. N.S. Ahmad, A. Waheed, M. Farman, and A. Qayyum Analgesic and anti-inflammatory effects of Pistacia integerrima extracts in mice J. Ethnopharmacol. 129 2010 250 253
5. S. Ahmad, M. Ali, and S.H. Ansari Phenolic constituents from the galls of Pistacia integerrima Stewart Indian J. Chem. B 50 2011 115
6. S. Ahmad, M. Ali, S.H. Ansari, and F. Ahmed Phytoconstituents from the galls of Pistacia integerrima Stewart J. Saudi Chem. Soc. 14 2010 409 412
7. S. Ansari, M. Ali, and J.S. Qadry Three new tetracyclic triterpenoids from galls of Pistacia integerrima Stew Pharmazie 49 1993 215 217
8. S. Ansari, and M. Ali Analgesic and anti-inflammatory activity of tetracyclic triterpenoids isolated from Pistacia integerrima Fitoterapia 67 1996 103 105
9. S. Ansari, M. Ali, and J. Qadry New tetracyclic triterpenoids from Pistacia integerrima galls Pharmazie 49 1994 356 357
10. S. Ansari, M. Ali, J. Qadry, and N. Siddiqui Analgesic activity of tetracyclic triterpenoids isolated from Pistacia integerrima galls Update Ayurveda 94 1994 73
11. S.H. Ansari, M. Ali, and J.S. Qadry Essential oils of Pistacia integerrima galls and their effect on the central nervous system Int. J. Pharmacogn. 31 1993 89 95
12. P.J. Barnes, and I.M. Adcock How do corticosteroids work in asthma? Ann. Intern. Med. 139 2003 359 370
13. P.J. Barnes, and M. Belvisi Nitric oxide and lung disease Thorax 48 1993 1034 1043
14. P.J. Barnes, K.F. Chung, and C.P. Page Inflammatory mediators of asthma: an update Pharmacol. Rev. 50 1998 515 596
15. A.F. Bento, R. Marcon, R.C. Dutra, R.F. Claudino, M. Cola, D.F. Pereira Leite, and J.B. Calixto β-Caryophyllene inhibits dextran sulfate sodium-induced colitis in mice through CB2 receptor activation and PPARγ pathway Am. J. Pathol. 178 2011 1153 1166
16. M.S. Blois Antioxidant determinations by the use of a stable free radical Nature 181 1958 1199 1200
17. T. Bolton Mechanisms of action of transmitters and other substances on smooth muscle Physiol. Rev. 59 1979 606
18. P.P. Bradley, R.D. Christensen, and G. Rothstein Cellular and extracellular myeloperoxidase in pyogenic inflammation Blood 60 1982 618 622
19. H. Campos, D. Xisto, W.A. Zin, and P.R. Rocco Phosphodiesterase inhibitors: new perspectives on an old therapy for asthma? J. Pneumol. 29 2003 405 412
20. G. Caramori, and I. Adcock Pharmacology of airway inflammation in asthma and COPD Pulm. Pharmacol. Ther. 16 2003 247 277
21. W.A. Catterall, A.L. Goldin, and S.G. Waxman International union of pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels Pharmacol. Rev. 57 2005 397
22. H. Cheong, S.Y. Ryu, M.H. Oak, S.H. Cheon, G.S. Yoo, and K.M. Kim Studies of structure activity relationship of flavonoids for the anti-allergic actions Arch. Pharm. Res. 21 1998 478 480
23. R.N. Chopra, I.C. Chopra, K.L. Handa, and L.D. Kapur Pistacia integerrima Stewart ex Brandis (Anacardiaceae) Chopras Indigenous Drugs of India 2nd edition 1958 DN Dhur and Sons Pvt. Ltd. Calcutta 377 379
24. J. Clevenger Apparatus for the determination of volatile oil J. Am. Pharm. Assoc. 17 1928 345 349
25. D. Conte Camerino, M.D. Lograno, A. Luca, M. Persichella, and F. Franconi The effects of the calcium channel agonist, Bay K 8644, on guinea pig ileum and rat uterine horn J. Pharm. Pharmacol. 39 1987 954 957
26. J. Crossland Pharmacological aspects of allergy Lewis Pharmacology 1980 Churchill Livingstone New York 393
27. B. Doumas, and H. Biggs Estimation of albumin in serum. Standard methods Clin. Chem. 7 1972 175 188
28. L.B. Fernandes, P.J. Henry, and R.G. Goldie Endothelins potentiates cholinergic nerve mediated contraction in human isolated bronchus Eur. Respir. J. 14 1999 439 442
29. S. Galli, and C.S. Lantz Allergy W. Paul, Fundamental Immunology 1998 Raven Press New York 1127 1174
30. S. Galli, and B. Wershil The two faces of mast cells Nature 381 1996 21 22
31. M.N. Ghosh Fundamentals of Experimental Pharmacology 3rd edition 2005 Hilton & Company Kolkata 110 120
32. C. Gopalakrishnan, D. Shankaranarayanan, S. Nazimudeen, S. Viswanathan, and L. Kameswaran Anti-inflammatory and CNS depressant activities of xanthones from Calophyllum inophyllum and Mesua ferrea Indian J. Pharmacol. 12 1980 181 191
33. P. Hart, C. Brand, C. Carson, T. Riley, R. Prager, and J. Finlay-Jones Terpinen-4-ol, the main component of the essential oil of Melaleuca alternifolia (tea tree oil), suppresses inflammatory mediator production by activated human monocytes Inflamm. Res. 49 2000 619 626
34. B. Havsteen Flavonoids, a class of natural products of high pharmacological potency Biochem. Pharmacol. 32 1983 1141 1148
35. P.A. Hutson, M.K. Church, T.P. Clay, P. Miller, and S.T. Holgate Early and late-phase bronchoconstriction after allergen challenge of nonanesthetized guinea pigs: I. The association of disordered airway physiology to leukocyte infiltration Am. Rev. Respir. Dis. 137 1988 548 557
36. E. Israel, J. Cohn, L. Dubé, J.M. Drazen, P. Ratner, W. Pleskow, A. DeGraff Jr, P. Chervinsky, S. Wasserman, and H. Nelson Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma 275 1996 JAMA 931 936
37. U.P. Joshi, and S. Mishra In vitro antioxidant and hepatoprotective activity of isolated compounds from Pistacia integerrima Aust. J. Med. Herbal. 22 2010 94
38. C. Khare Encyclopedia of Indian Medicinal Plants 2004 Springes-Verlag Berlin/Heidelberg/New York 494
39. J.C. Kips, J. Tavernier, and R.A. Pauwels Tumor necrosis factor causes bronchial hyperresponsiveness in rats Am. Rev. Respir. Dis. 145 1992 332 336
40. L. Krenn Inhibition of angiogenesis and inflammation by an extract of red clover (Trifolium pratense L.) Phytomedicine 16 2009 1083 1088
41. P.S. Kumar, K. Soni, S. Jadhav, N. Doshi, and M. Saraf Mechanism of spasmolytic activity of a fraction of Sarcostemma brevistigma Wight Indian J. Exp. Biol. 45 2007 419 424
42. J. Lefort, M. Singer, D. Leduc, P. Renesto, M.A. Nahori, M. Huerre, C. Créminon, M. Chignard, and B.B. Vargaftig Systemic administration of endotoxin induces bronchopulmonary hyperreactivity dissociated from TNF-α formation and neutrophil sequestration into the murine lungs J. Immunol. 161 1998 474 480
43. J.C. Leza, E. Salas, G. Sawicki, J.C. Russell, and M.W. Radomski The effects of stress on homeostasis in JCR-LA-cp rats: the role of nitric oxide J. Pharmacol. Exp. Ther. 286 1998 1397 1403
44. O. Lowry, N. Rosebrough, A. Farr, and R. Randall Protein estimation with the Folin phenol reagent J. Biol. Chem. 193 1951 265 275
45. P.J.C. Magalhães, S. Lahlou, and J.H. Leal-Cardoso Antispasmodic effects of the essential oil of Croton nepetaefolius on guinea-pig ileum: a myogenic activity Fundam. Clin. Pharmacol. 18 2004 539 546
46. K. McConalogue, and J.B. Furness 3 gastrointestinal neurotransmitters Baillières Clin. Endocrinol. Metab. 8 1994 51 76
47. R. Medeiros, G. Passos, C. Vitor, J. Koepp, T. Mazzuco, L. Pianowski, M. Campos, and J. Calixto Effect of two active compounds obtained from the essential oil of Cordia verbenacea on the acute inflammatory responses elicited by LPS in the rat paw Br. J. Pharmacol. 151 2007 618 627
48. K. Mehla, S. Balwani, A. Kulshreshtha, D. Nandi, P. Jaisankar, and B. Ghosh Ethyl gallate isolated from Pistacia integerrima Linn. inhibits cell adhesion molecules by blocking AP-1 transcription factor J. Ethnopharmacol. 137 2011 1345 1352
49. E. Middleton, C. Kandaswami, and T.C. Theoharides The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer Pharmacol. Rev. 52 2000 673 751
50. B. Mishra Bhav Prakash, Brahmashankar Mishra, Vedic Literature Collection 1969 Maharshi University of Management United States 131
51. A. Nair, C. Tamhankar, and M. Saraf Studies on the mast cell stabilizing activity of Vitex negundo Linn Indian Drugs 32 1995 277 282
52. NIST, 1998. Mass spectral search program for the NIST/EPA/NIH mass spectral library.ver. 1.6d.
53. OECD, 2001. Guideline for testing of chemicals, acute oral toxicity - fixed dose procedure no. 420, Adopted: OECD/OCDE. pp. 1-14.
54. Y. Ohkawara, K. Yamauchi, Y. Tanno, G. Tamura, H. Ohtani, H. Nagura, K. Ohkuda, and T. Takishima Human lung mast cells and pulmonary macrophages produce tumor necrosis factor-alpha in sensitized lung tissue after IgE receptor triggering Am. J. Respir. Cell Mol. Biol. 7 1992 385
55. D. Pathak, K. Pathak, and A. Singla Flavonoids as medicinal agents-recent advances Fitoterapia 62 1991 371 389
56. D. Ribatti, A. Vacca, L. Roncali, and F. Dammacco The chick embryo chorioallantoic membrane as a model for in vivo research on anti-angiogenesis Curr. Pharm. Biotechnol. 1 2000 73 82
57. U. Shinde, K. Kulkarni, A. Phadke, A. Nair, A. Mungantiwar, V. Dikshit, and M. Saraf Mast cell stabilizing and lipoxygenase inhibitory activity of cedrus deodara (Roxb.) Loud. wood oil Indian J. Exp. Biol. 37 1999 258 261
58. M. Spedding, and R. Paoletti Classification of calcium channels and the sites of action of drugs modifying channel function Pharmacol. Rev. 44 1992 363
59. J. Spond, R. Chapman, J. Fine, H. Jones, W. Kreutner, T. Kung, and M. Minnicozzi Comparison of PDE 4 inhibitors, rolipram and SB 207499, in a rat model of pulmonary neutrophilia Pulm. Pharmacol. Ther. 14 2001 157 164
60. A.W. Taylor-Robinson, R.S. Phillips, A. Severn, S. Moncada, and F.Y. Liew The role of TH1 and TH2 cells in a rodent malaria infection Science 260 1993 1931 1934
61. T. Tomita Electrical activity (spikes and slow waves) in gastrointestinal smooth muscle Smooth Muscle 1981 127 156
62. N. Tsopanoglou, G. Haralabopoulos, and M. Maragoudakis Opposing effects on modulation of angiogenesis by protein kinase C and cAMP-mediated pathways J. Vasc. Res. 31 1994 195 204
63. N. Tsopanoglou, E. Pipili-Synetos, and M. Maragoudakis Protein kinase C involvement in the regulation of angiogenesis J. Vasc. Res. 30 1993 202 208
64. B. Uvnas Mast cells and histamine release Indian J. Pharmacol. 1 1969 23 32
65. R.M.C. Vasconcelos, F.C. Leite, J.A. Leite, S. Rodrigues Mascarenhas, L.C. Rodrigues, and M.R. Piuvezam Synthesis, acute toxicity and anti-inflammatory effect of bornyl salicylate, a salicylic acid derivative Immunopharmacol. Immunotoxicol. 34 2012 1028 1038
66. W. Wong, and D.S. Koh Advances in immunopharmacology of asthma Biochem. Pharmacol. 59 2000 1323 1335
67. World Health Organization (WHO) 2002. Prevention of allergic asthma, Geneva, 3.
68. G. Xie, N. Chen, L.W. Soromou, F. Liu, Y. Xiong, Q. Wu, H. Li, H. Feng, and G. Liu p-Cymene protects mice against lipopolysaccharide-induced acute lung injury by inhibiting inflammatory cell activation Molecules 17 2012 8159 8173
69. Q. Xie, Y. Kashiwabara, and C. Nathan Role of transcription factor NF-Kβ/Rel in induction of nitric oxide synthase J. Biol. Chem. 269 1994 4705 4708
70. R.-B. Yang, M.R. Mark, A. Gray, A. Huang, M.H. Xie, M. Zhang, A. Goddard, W.I. Wood, A.L. Gurney, and P.J. Godowski Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signaling Nature 395 1998 284 288
71. Zaditor™, 1999. U.S. Food and Drug Administration, Center for Drug Evaluation and Research. Pharmacological Review. Novartis Pharmaceuticals Corporation, East Hanover, New Jersey. NDA 21-066. from http://www.accessdata. fda.gov/drugsatfda-docs/nda/99/21-066